‘Tomudex’ (ZD1694): Results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia
- 30 November 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (12) , 1945-1954
- https://doi.org/10.1016/0959-8049(95)00502-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Temporal Patterns in Colorectal Cancer Incidence, Survival, and Mortality From 1950 Through 1990JNCI Journal of the National Cancer Institute, 1994
- Chemotherapy for Colorectal CancerNew England Journal of Medicine, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Systemic treatment of colorectal cancerEuropean Journal Of Cancer, 1993
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Folinic acid + 5-Fluorouracil (5-FU) versus equidose 5-FU in advanced colorectal cancer. Phase III study of ‘GISCAD’ (Italian Group for the Study of Digestive Tract Cancer)Annals of Oncology, 1991
- Cancer in the European community and its member statesEuropean Journal of Cancer and Clinical Oncology, 1990
- Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1989
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977